Milestone Scientific (MLSS) Change in Accured Expenses (2010 - 2026)
Milestone Scientific (MLSS) reported Change in Accured Expenses of $58329.0 for Q1 2026, up 112.14% on a YoY basis from $27495.2 in Q1 2025, and up 131.58% sequentially from -$184690.0 in Q4 2025.
Milestone Scientific (MLSS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Milestone Scientific (MLSS) has 17 years of Change in Accured Expenses data on file, last reported at $58329.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 112.14% year-over-year to $58329.0; the trailing twelve-month figure through Mar 2026 stood at -$262405.0 (down 88.16% YoY), and the FY2025 full-year result was -$801116.0, down 1234.56% from the prior year.
- Change in Accured Expenses improved to $58329.0 in Q1 2026, from -$184690.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $399980.0 in Q4 2023 to a low of -$480382.0 in Q1 2025.
- A 5-year average of -$33987.6 and a median of -$81797.0 in 2022 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 436.32% in 2023, while the deepest fall reached 418.0% in 2023.
- Tracing MLSS's Change in Accured Expenses over 5 years: stood at $74579.0 in 2022, then soared by 436.32% to $399980.0 in 2023, then slipped by 21.34% to $314609.0 in 2024, then slumped by 158.7% to -$184690.0 in 2025, then soared by 131.58% to $58329.0 in 2026.
- Business Quant data shows MLSS's Change in Accured Expenses at $58329.0 in Q1 2026, -$184690.0 in Q4 2025, and -$208890.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -260.40 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -32.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 103.88 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -151.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 5.38 Mn |
| 10 | Milestone Scientific | 33.00 Mn | 31.35 Mn | 1.56 Mn | 58,329.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58,329.00 |
| Mar 31, 2026 | 58,329.00 |
| Dec 31, 2025 | -184,690.00 |
| Dec 31, 2025 | -184,690.00 |
| Sep 30, 2025 | -208,890.00 |
| Sep 30, 2025 | -208,890.00 |
| Jun 30, 2025 | 72,846.00 |
| Jun 30, 2025 | 72,846.00 |
| Mar 31, 2025 | -480,382.00 |
| Mar 31, 2025 | -480,382.00 |
| Dec 31, 2024 | 314,609.00 |
| Dec 31, 2024 | 314,609.00 |
| Sep 30, 2024 | 197,438.00 |
| Sep 30, 2024 | 197,438.00 |
| Jun 30, 2024 | -171,127.00 |
| Jun 30, 2024 | -171,127.00 |
| Mar 31, 2024 | -270,310.00 |
| Mar 31, 2024 | -270,310.00 |
| Dec 31, 2023 | 399,980.00 |
| Dec 31, 2023 | 399,980.00 |